Recommendations for the prevention of neonatal ophthalmia

Despite the decreasing prevalence of Neisseria gonorrhoeae in Canada, the Canadian Paediatric Society recommends that, as soon as possible after birth, all infants receive prophylaxis with silver nitrate, tetracycline or erythromycin, to reduce the risk of neonatal ophthalmia due to this organism. T...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Paediatrics & child health 2002-09, Vol.7 (7), p.480-483
Format:	Artikel
Sprache:	eng
Schlagworte:	Position Statement (ID 2002–03)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	483
container_issue	7
container_start_page	480
container_title	Paediatrics & child health
container_volume	7
description	Despite the decreasing prevalence of Neisseria gonorrhoeae in Canada, the Canadian Paediatric Society recommends that, as soon as possible after birth, all infants receive prophylaxis with silver nitrate, tetracycline or erythromycin, to reduce the risk of neonatal ophthalmia due to this organism. The use of these agents may also provide some benefit in the prevention of ophthalmia due to other organisms. As well, the Canadian Paediatric Society supports routine pre-natal screening for N gonorrhoeae and Chlamydia trachomatis, and the treatment of identified infections during pregnancy.
doi_str_mv	10.1093/pch/7.7.480
format	Article
fullrecord	<record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2795679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20046325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2630-212a13583bac19be1686b9c9a09cb6520f6ab9df6dfa6c66b3a17df5a03b5c8d3</originalsourceid><addsrcrecordid>eNpVkE1LxDAQhoMo7rp68i69S3fz0aTJRZDFL1gQRM9hkia20jYlrQv-e7OsLsocZph5553hQeiS4CXBiq0GW6_KZbksJD5Cc6KIzEkh-XGqKeZ5iaWcobNx_MC4IBLTUzSjqRSM8jlSL86GrnN9BVMT-jHzIWZT7bIhuq3rd70s-Kx3oYcJ2iwM9VRD2zVwjk48tKO7-MkL9HZ_97p-zDfPD0_r201uqWA4p4QCYVwyA5Yo44iQwiirACtrBKfYCzCq8qLyIKwQhgEpK88BM8OtrNgC3ex9h0_TucqmpyK0eohNB_FLB2j0_0nf1Po9bDUtFRelSgbXewMbwzhG5w-7BOsdQZ0I6jJFIpjUV3_PHbS_yNg3XEdukA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Recommendations for the prevention of neonatal ophthalmia</title><source>PubMed Central (Open Access)</source><source>EZB Electronic Journals Library</source><source>Oxford Journals</source><description>Despite the decreasing prevalence of Neisseria gonorrhoeae in Canada, the Canadian Paediatric Society recommends that, as soon as possible after birth, all infants receive prophylaxis with silver nitrate, tetracycline or erythromycin, to reduce the risk of neonatal ophthalmia due to this organism. The use of these agents may also provide some benefit in the prevention of ophthalmia due to other organisms. As well, the Canadian Paediatric Society supports routine pre-natal screening for N gonorrhoeae and Chlamydia trachomatis, and the treatment of identified infections during pregnancy.</description><identifier>ISSN: 1205-7088</identifier><identifier>EISSN: 1918-1485</identifier><identifier>DOI: 10.1093/pch/7.7.480</identifier><identifier>PMID: 20046325</identifier><language>eng</language><publisher>England: Pulsus Group Inc</publisher><subject>Position Statement (ID 2002–03)</subject><ispartof>Paediatrics & child health, 2002-09, Vol.7 (7), p.480-483</ispartof><rights>2002 Canadian Paediatric Society. All rights reserved</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2630-212a13583bac19be1686b9c9a09cb6520f6ab9df6dfa6c66b3a17df5a03b5c8d3</citedby><cites>FETCH-LOGICAL-c2630-212a13583bac19be1686b9c9a09cb6520f6ab9df6dfa6c66b3a17df5a03b5c8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795679/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795679/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27926,27927,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20046325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Recommendations for the prevention of neonatal ophthalmia</title><title>Paediatrics & child health</title><addtitle>Paediatr Child Health</addtitle><description>Despite the decreasing prevalence of Neisseria gonorrhoeae in Canada, the Canadian Paediatric Society recommends that, as soon as possible after birth, all infants receive prophylaxis with silver nitrate, tetracycline or erythromycin, to reduce the risk of neonatal ophthalmia due to this organism. The use of these agents may also provide some benefit in the prevention of ophthalmia due to other organisms. As well, the Canadian Paediatric Society supports routine pre-natal screening for N gonorrhoeae and Chlamydia trachomatis, and the treatment of identified infections during pregnancy.</description><subject>Position Statement (ID 2002–03)</subject><issn>1205-7088</issn><issn>1918-1485</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LxDAQhoMo7rp68i69S3fz0aTJRZDFL1gQRM9hkia20jYlrQv-e7OsLsocZph5553hQeiS4CXBiq0GW6_KZbksJD5Cc6KIzEkh-XGqKeZ5iaWcobNx_MC4IBLTUzSjqRSM8jlSL86GrnN9BVMT-jHzIWZT7bIhuq3rd70s-Kx3oYcJ2iwM9VRD2zVwjk48tKO7-MkL9HZ_97p-zDfPD0_r201uqWA4p4QCYVwyA5Yo44iQwiirACtrBKfYCzCq8qLyIKwQhgEpK88BM8OtrNgC3ex9h0_TucqmpyK0eohNB_FLB2j0_0nf1Po9bDUtFRelSgbXewMbwzhG5w-7BOsdQZ0I6jJFIpjUV3_PHbS_yNg3XEdukA</recordid><startdate>20020901</startdate><enddate>20020901</enddate><general>Pulsus Group Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20020901</creationdate><title>Recommendations for the prevention of neonatal ophthalmia</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2630-212a13583bac19be1686b9c9a09cb6520f6ab9df6dfa6c66b3a17df5a03b5c8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Position Statement (ID 2002–03)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Paediatrics & child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations for the prevention of neonatal ophthalmia</atitle><jtitle>Paediatrics & child health</jtitle><addtitle>Paediatr Child Health</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>7</volume><issue>7</issue><spage>480</spage><epage>483</epage><pages>480-483</pages><issn>1205-7088</issn><eissn>1918-1485</eissn><abstract>Despite the decreasing prevalence of Neisseria gonorrhoeae in Canada, the Canadian Paediatric Society recommends that, as soon as possible after birth, all infants receive prophylaxis with silver nitrate, tetracycline or erythromycin, to reduce the risk of neonatal ophthalmia due to this organism. The use of these agents may also provide some benefit in the prevention of ophthalmia due to other organisms. As well, the Canadian Paediatric Society supports routine pre-natal screening for N gonorrhoeae and Chlamydia trachomatis, and the treatment of identified infections during pregnancy.</abstract><cop>England</cop><pub>Pulsus Group Inc</pub><pmid>20046325</pmid><doi>10.1093/pch/7.7.480</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1205-7088
ispartof	Paediatrics & child health, 2002-09, Vol.7 (7), p.480-483
issn	1205-7088 1918-1485
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2795679
source	PubMed Central (Open Access); EZB Electronic Journals Library; Oxford Journals
subjects	Position Statement (ID 2002–03)
title	Recommendations for the prevention of neonatal ophthalmia
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T22%3A51%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20for%20the%20prevention%20of%20neonatal%20ophthalmia&rft.jtitle=Paediatrics%20&%20child%20health&rft.date=2002-09-01&rft.volume=7&rft.issue=7&rft.spage=480&rft.epage=483&rft.pages=480-483&rft.issn=1205-7088&rft.eissn=1918-1485&rft_id=info:doi/10.1093/pch/7.7.480&rft_dat=%3Cpubmed_cross%3E20046325%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20046325&rfr_iscdi=true